Simplex Trading’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-85,800
| Closed | -$775K | – | 10286 |
|
|
2025
Q4 | $775K | Buy |
85,800
+72,600
| +550% | +$543K | ﹤0.01% | 2878 |
|
|
2025
Q3 | $41K | Sell |
13,200
-2,200
| -14% | -$5.83K | ﹤0.01% | 6661 |
|
|
2025
Q2 | $32K | Buy |
15,400
+7,700
| +100% | +$12.4K | ﹤0.01% | 6356 |
|
|
2025
Q1 | $8K | Sell |
7,700
-24,000
| -76% | -$41.2K | ﹤0.01% | 7273 |
|
|
2024
Q4 | $69K | Sell |
31,700
-500
| -2% | -$1.13K | ﹤0.01% | 5542 |
|
|
2024
Q3 | $70K | Buy |
32,200
+29,300
| +1,010% | +$67.4K | ﹤0.01% | 5573 |
|
|
2024
Q2 | $6K | Sell |
2,900
-8,000
| -73% | -$33.2K | ﹤0.01% | 7807 |
|
|
2024
Q1 | $59K | Sell |
10,900
-32,900
| -75% | -$150K | ﹤0.01% | 6118 |
|
|
2023
Q4 | $108K | Buy |
43,800
+42,400
| +3,029% | +$403K | ﹤0.01% | 5305 |
|
|
2023
Q3 | $48K | Buy |
1,400
+300
| +27% | +$10.4K | ﹤0.01% | 5850 |
|
|
2023
Q2 | $36K | Sell |
1,100
-28,400
| -96% | -$979K | ﹤0.01% | 6163 |
|
|
2023
Q1 | $988K | Buy |
29,500
+6,400
| +28% | +$249K | ﹤0.01% | 2595 |
|
|
2022
Q4 | $757K | Buy |
23,100
+13,600
| +143% | +$403K | ﹤0.01% | 2738 |
|
|
2022
Q3 | $331K | Buy |
+9,500
| New | +$210K | ﹤0.01% | 3956 |
|
Other funds holding VTYX
Simplex Trading's VTYX Position: Q4 2025 in Review
Simplex Trading sold out of Ventyx Biosciences (VTYX) in Q4 2025, closing a stake of 49,959 shares — an estimated $373K sold.
Simplex Trading first reported a position in VTYX in Q4 2023 and held it in 7 quarters. The position peaked at $327K in Q4 2024. 139 funds tracked by Wall St. Rank hold VTYX as of Q4 2025.
- Simplex Trading reported no remaining Ventyx Biosciences position as of Q4 2025 after selling out during the quarter.
- Simplex Trading sold 49,959 Ventyx Biosciences shares in Q4 2025, an estimated $373K.
- Simplex Trading first reported a position in Ventyx Biosciences in Q4 2023 and held it in 7 quarters.
- Simplex Trading's Ventyx Biosciences position peaked at $327K in Q4 2024.
- 139 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q4 2025.
Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.